SCHEMBL9719342

SCHEMBL9719342

O=C1C(Cc2ccncc2)c2ccccc2N1c1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.47
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLC6A2 P23975 1/20 0.40
FLT1 P17948 1/20 0.39
KDR P35968 1/20 0.39
MGLL Q99685 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
THPO P40225 1/20 0.38
LMNA P02545 1/20 0.37
ROCK2 O75116 2/20 0.37
ROCK1 Q13464 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599210 0.87 ALDH1A1 (0.48) ALOX5ALDH1A1SMN1; SMN2CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8805740 0.86 MAPK1 (0.48) ALOX5ALDH1A1SMN1; SMN2CYP1A2CYP3A4
SCHEMBL4687956 0.80 ALOX5 (0.50) ALOX5ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL4692248 0.77 ALOX5 (0.47) ALOX5LMNA
SCHEMBL9719340 0.74 GSK3B (0.51) ALOX5SMN1; SMN2CYP11B1CYP11B2CYP1A2
SCHEMBL9719345 0.74 ROCK2 (0.51) ALOX5ALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL9389645 0.72 ALOX5 (0.41) ALOX5ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL27753786 0.72 ALOX5 (0.47) ALOX5ALDH1A1KDM4ESMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL9138618 0.71 MGLL (0.46) ALDH1A1KDM4ESMN1; SMN2SLC6A2MGLL
SCHEMBL9288404 0.71 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241006-B1 3,3-DISUBSTITUTED INDOLINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-02-28 EP claimed
WO-1992000760-A1 METHOD OF TREATING NEUROLOGICAL DYSFUNCTION USING NEUROTRANSMITTER ENHANCES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-01-23 WO disclosed